The world’s first remote robotic ultrasound system, MGIUS-R3, received Class III medical device qualification by the China National Medical Product Administration (NMPA) on May 13, 2020, allowing it to enter the Chinese market and provide state-of-art long-distance ultrasound diagnostic services. Class III medical device qualification by the China National Medical Product Administration (NMPA) MGIUS-R3 was also certified through the EC Full Quality Assurance System in March, which means...

MGI is proud to announce that its solutions are being used for large-scale testing and sequencing for epidemic surveillance of COVID-19 in India. ICMR (The Indian Council of Medical Research), the top body in India leading the response to the COVID-19 pandemic, has ordered nucleic acid extraction kits for more than one million RNA extractions from MGI. ICMR has also approved the import license for procurement of the MGI viral RNA extraction kits to India. India’s Punjab state governmen...

Brisbane, Australia; April 29, 2020 – Federal Minister for Health, the Hon Greg Hunt MP, and Minderoo Foundation Chairman, Dr Andrew Forrest AO,have announced the ground-breaking partnership formed between the Australian Federal Government and Minderoo Foundation to secure an abundance of COVID-19 testing kits and other equipment, in a mission to eliminate COVID-19 in Australia. Global genomics leader BGI Group (BGI) has joined the initiative named "Security Through Accelerated Testing" (STAT)...

TORONTO, May 13, 2020 – Today, Sinai Health, a significant centre for COVID-19 testing in Canada, will receive a donation from The Mammoth Foundation of key laboratory equipment to increase its COVID-19 detection capability. The Mammoth Foundation has donated testing equipment produced by genomics leader BGI Group, in addition to installation, training and logistics support. At the heart of this donation, among other equipment, is the MGISP-960 automated viral RNA extraction and sample prepara...

May 6, 2020 BGI Genomics and MGI, members of the BGI Group, are jointly providing a high throughput, clinically validated workflow to address major bottlenecks for large-scale COVID-19 testing. The solution includes BGI’s Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2, which is the authorized device by Health Canada, as well as MGI’s MGIEasy Nucleic Acid Extraction Kit and MGISP-960RS Automated Sample Preparation System. BGI Genomics announced today that its subsidiary BGI Americas...

PARIS, April 17, 2020 -- MGI, a global life science technology company of BGI Group, has signed an agreement with the Health Ministry of France to provide equipment and materials to enable testing of 2 million people throughout the country for COVID-19. MGI is working with hospitals around France to deliver the urgently needed testing supplies and rapidly scale up capacity to 40,000 tests per day for the population. “I know that I can count on the full mobilization of BGI Group to supp...